We curate a digest of the latest news in our field for advocates, policymakers, community coalitions and all who work toward shaping policies and practices to effectively prevent substance use and treat addiction.
The U.S. Food and Drug Administration announced this week it is taking action to restrict illegal importing of the veterinary pharmaceutical xylazine, which has increasingly been found in illicit fentanyl and involved in a growing number of overdose deaths.
The Drug Enforcement Administration is proposing to reinstate federal rules, waived during the pandemic, that require patients to see a doctor in person to receive an initial prescription for controlled medicines such as OxyContin or Adderall.
A new clinical trial will compare the ability of patients to remain in treatment for opioid addiction when prescribed buprenorphine or methadone in an office setting, STAT reports.
View our curated digest of the latest research news, including a study identifying the frequency of medications for opioid use disorder (MOUD) prior authorization prohibitions in state laws.
The federal government will allow states to use Medicaid funds to provide addiction treatment and other medical services for people in state jails and prisons, AP reports.
A new study finds deaths from methamphetamine rose 50-fold between 1999 and 2021 in the United States, HealthDay reports. Many of the deaths also involved heroin or fentanyl.
After a Food and Drug Administration advisory panel voted to make the nasal spray version of the opioid overdose antidote naloxone (Narcan) available without a prescription, experts say the medication’s cost will determine how many people can benefit from it.
Find more of our must-reads in policy news, including the Biden administration's plans to allow Medicaid to cover addiction and other care for people who are incarcerated.
View our curated digest of the latest research news, including a study examining the association between child maltreatment and substance use disorder across emerging adulthood.
The cost of buprenorphine treatment for opioid use disorder decreased from 2015 to 2020, according to a new study. But costs varied widely depending on a patient’s insurance, Axios reports.
View our curated digest of the latest research news, including the association between opioid tapering and subsequent health care use, medication adherence and chronic condition control.
The federal government is taking a number of steps to crack down on fentanyl smuggling along the southern border, President Biden said Tuesday night in his State of the Union address.
As more data emerges on marijuana’s health effects, policymakers are seeking to increase regulation and oversight of the loosely regulated marijuana marketplace, Politico reports.
Nearly two-thirds of adults support prohibiting menthol cigarette sales, while more than half support banning all tobacco product sales, according to a new survey from the Centers for Disease Control and Prevention.
View our curated digest of the latest research news, including the association between state cannabis legalization and psychosis-related health care utilization.
View our curated digest of the latest research news, including an examination of awareness of, susceptibility to and use of oral nicotine pouches in young adults as well as comparative risk perceptions with smokeless tobacco.
This website uses cookies. We use cookies and similar technologies to give you the best experience. By using this website, you accept our Privacy Policy and Terms of Use.
Get Support
